Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析

◆英語タイトル:Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1648
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Charles River Laboratories International Inc (CRL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The organization also offers clinical, manufacturing and operations and staffing support. It focuses on providing solutions for cardiovascular, central nervous system, metabolic inflammation, oncology, ophthalmology, respiratory and musculoskeletal therapeutic areas. Charles River caters products and services to pharmaceutical and biotechnology companies, government agencies, as well as leading hospitals and academic institutions. It operates through a network facilities located worldwide. Charles River is headquartered in Wilmington, Massachusetts, the US.

Charles River Laboratories International Inc Key Recent Developments

Mar 30,2020 Charles River Laboratories and Deciphex form a partnership to enhance drug discovery & development with digital pathology
Mar 04,2020 Charles River Laboratories adds Nancy C. Andrews, M.D., Ph.D., to board of directors
Feb 11,2020 Charles River Laboratories announces fourth-quarter and full-year 2019 results and provides 2020 guidance
Jan 23,2020 Strategic Partnership seen as a game changer for Edinburgh-based Fios Genomics

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Charles River Laboratories International Inc – Key Facts
Charles River Laboratories International Inc – Key Employees
Charles River Laboratories International Inc – Key Employee Biographies
Charles River Laboratories International Inc – Major Products and Services
Charles River Laboratories International Inc – History
Charles River Laboratories International Inc – Company Statement
Charles River Laboratories International Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Charles River Laboratories International Inc – Business Description
Business Segment: Discovery and Safety Assessment
Overview
Performance
Business Segment: Manufacturing Support
Overview
Performance
Business Segment: Research Models and Services
Overview
Performance
Geographical Segment: Asia Pacific
Target Markets
Performance
Geographical Segment: Canada
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other
Target Markets
Performance
Geographical Segment: US
Performance
Charles River Laboratories International Inc – Corporate Strategy
Charles River Laboratories International Inc – SWOT Analysis
SWOT Analysis – Overview
Charles River Laboratories International Inc – Strengths
Charles River Laboratories International Inc – Weaknesses
Charles River Laboratories International Inc – Opportunities
Charles River Laboratories International Inc – Threats
Charles River Laboratories International Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Charles River Laboratories International Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 30, 2020: Charles River Laboratories and Deciphex form a partnership to enhance drug discovery & development with digital pathology
Mar 04, 2020: Charles River Laboratories adds Nancy C. Andrews, M.D., Ph.D., to board of directors
Feb 11, 2020: Charles River Laboratories announces fourth-quarter and full-year 2019 results and provides 2020 guidance
Jan 23, 2020: Strategic Partnership seen as a game changer for Edinburgh-based Fios Genomics
Jan 16, 2020: Charles River Laboratories and Fios Genomics form a strategic alliance to provide bioinformatics-driven drug discovery and safety assessment
Jan 14, 2020: Takeda partners Charles River to develop preclinical candidates
Dec 17, 2019: Charles River Laboratories to acquire HemaCare for $380m
Dec 10, 2019: Charles River announces strategic partnership with Bit Bio, increasing portfolio of translational drug discovery technologies
Dec 04, 2019: Charles River Laboratories updates Tumor Model Compendium
Nov 06, 2019: Charles River Laboratories announces third-quarter 2019 results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Charles River Laboratories International Inc, Key Facts
Charles River Laboratories International Inc, Key Employees
Charles River Laboratories International Inc, Key Employee Biographies
Charles River Laboratories International Inc, Major Products and Services
Charles River Laboratories International Inc, History
Charles River Laboratories International Inc, Subsidiaries
Charles River Laboratories International Inc, Key Competitors
Charles River Laboratories International Inc, Ratios based on current share price
Charles River Laboratories International Inc, Annual Ratios
Charles River Laboratories International Inc, Annual Ratios (Cont...1)
Charles River Laboratories International Inc, Annual Ratios (Cont...2)
Charles River Laboratories International Inc, Interim Ratios
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Charles River Laboratories International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Charles River Laboratories International Inc, Performance Chart (2015 - 2019)
Charles River Laboratories International Inc, Ratio Charts
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IHI Corporation:企業のM&A・事業提携・投資動向
    IHI Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IHI Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Berkshire Hathaway Energy Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Berkshire Hathaway Energy Company (BHE) a subsidiary of Berkshire Hathaway Inc., generates, transmits, stores, distributes, and supplies electricity; and procures, transports, distributes and sells natural gas through its subsidiaries. It generates power through diversified energy sources su …
  • S. Kumars Nationwide Ltd:企業の戦略・SWOT・財務情報
    S. Kumars Nationwide Ltd - Strategy, SWOT and Corporate Finance Report Summary S. Kumars Nationwide Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Revance Therapeutics Inc (RVNC)-医療機器分野:企業M&A・提携分析
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Ricerca Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Ricerca Biosciences LLC (Ricerca), formerly Ricerca Inc, a subsidiary of Olon SpA, is a contract research organization that offers accelerate drug development services. The organization's services comprise drug safety and metabolism, chemical development, agrochemicals and other commercial s …
  • Hunting PLC (HTG)-石油・ガス分野:企業M&A・提携分析
    Summary Hunting PLC (Hunting) is a provider of energy services that manufactures and distributes products for the extraction of oil and gas. The company provides products for the construction, completion, and re-completion of wellbore development, and intervention and subsea support of wellbore prod …
  • TeaM Energy Corp:企業の戦略的SWOT分析
    TeaM Energy Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Endo International Plc (ENDP)-製薬・医療分野:企業M&A・提携分析
    Summary Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies including Endo Pharmaceuticals, Paladin Labs, Par Pharmaceutical, …
  • Power Assets Holdings Limited:企業の戦略・SWOT・財務情報
    Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Wellington Pub Company PLC:企業の戦略・SWOT・財務情報
    Wellington Pub Company PLC - Strategy, SWOT and Corporate Finance Report Summary Wellington Pub Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bulgarian Telecommunications Company (VIVACOM):企業の戦略的SWOT分析
    Bulgarian Telecommunications Company (VIVACOM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Leukocare AG-製薬・医療分野:企業M&A・提携分析
    Summary Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting i …
  • Time Dotcom Berhad (TIMECOM):企業の財務・戦略的SWOT分析
    Time Dotcom Berhad (TIMECOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Brinker International, Inc.:企業の戦略・SWOT・財務情報
    Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Advance Synergy Berhad:企業の戦略・SWOT・財務情報
    Advance Synergy Berhad - Strategy, SWOT and Corporate Finance Report Summary Advance Synergy Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • KC Cottrell Co Ltd (119650):企業の財務・戦略的SWOT分析
    KC Cottrell Co Ltd (119650) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Immco Diagnostics Inc-製薬・医療分野:企業M&A・提携分析
    Summary IMMCO Diagnostics Inc (IMMCO), a subsidiary of Trinity Biotech Plc is a biotechnology company that offers autoimmune disease diagnostic solutions. The company offers a wide range of IFAs, EIAs, Line Immunoassays and Western Blots for an extensive variety of autoimmune disorders. It also deve …
  • Myers Industries Inc (MYE):企業の財務・戦略的SWOT分析
    Summary Myers Industries Inc (Myers) is a chemical company that manufactures and distributes plastic and rubber products. The company offers plastic storage containers, rubber tire repair products, custom plastic and rubber products, tire balancers and tire retread products. It also provides materia …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • San Miguel Corp:企業の戦略・SWOT・財務情報
    San Miguel Corp - Strategy, SWOT and Corporate Finance Report Summary San Miguel Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆